Dr. Devan Szczepanski, MD, MA, ABFM is the Founder of Reformative Medicine® and Owner & CEO of NuWell Medicine™, where she is building next-generation clinical infrastructure at the intersection of genomics, artificial intelligence, and longitudinal care.

A board-certified physician with advanced training in systems-based care and human performance, Dr. Szczepanski is focused on integrating genomic insights directly into real-world clinical workflows. Her work centers on developing AI-assisted clinical models that enable earlier intervention, personalized treatment strategies, and continuous patient optimization over time.

Through NuWell Medicine, she is pioneering practical, scalable approaches to “genomics at the point of care”—bridging the gap between rapidly advancing biological data and everyday medical decision-making. Her broader mission is to establish the data foundation necessary for precision medicine to move from theory to standard practice.

Dr. Szczepanski’s work sits at the convergence of medicine, data science, and systems design, with a focus on building durable platforms that redefine how care is delivered, measured, and improved across the lifespan.